View Older Stories View More Recent Stories
-
BMO Capital Upgrades Royal Gold (RGLD) to Outperform
-
BMO Capital Remains Bullish on MDC Partners (MDCA) Following Investor Meetings
-
Sandstorm Gold Ltd (SAND) Announces Gross Proceeds of $57.5M from Bought Deal Financing
-
Sandstorm Gold Announces Closing of Bought Deal Financing
-
Eclipse Resources Corporation Announces Closing of Public Offering of Common Stock
-
AdvancePierre Foods Announces Launch of Initial Public Offering
-
Superior Plus to Sell Construction Products Distribution Business for US $325 Million
-
Front Street Capital Charitable Foundation's 2016 Summer Solstice Fundraiser Exceeds Expectations: Over $300,000 Raised
-
BMO Capital Downgrades First Potomac (FPO) to Market Perform
-
National Storage Affiliates Trust Announces Pricing of Upsized Public Offering of Common Shares
-
Notable Analyst Rating Changes 6/29: (DYN) (CNC) (DAR) Upgraded; (HAR) (ESPR) (ZION) Downgraded
-
BMO Capital Starts Valeant Pharmaceuticals (VRX) at Market Perform
-
Eclipse Resources (ECR) Prices 37.5M Stock Offering at $3.50/Share
-
Eclipse Resources Corporation Prices Public Offering of Common Stock
-
BMO Capital Starts Impax Laboratories (IPXL) at Market Perform
-
BMO Capital Starts Endo International plc (ENDP) at Market Perform
-
BMO Capital Starts Amphastar Pharmaceuticals (AMPH) at Market Perform
-
BMO Capital Starts Jazz Pharmaceuticals (JAZZ) at Outperform
-
BMO Capital Starts Pacira Pharmaceuticals (PCRX) at Underperform
-
BMO Capital Starts Flexion Therapeutics (FLXN) at Outperform
-
BMO Capital Starts Horizon Pharma (HZNP) at Outperform
-
BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
-
BMO Capital Starts Sage Therapeutics (SAGE) at Outperform
-
BMO Capital Starts Mallinckrodt plc (MNK) at Outperform
-
Eclipse Resources (ECR) Announces 37.5M Share Common Stock Offering
-
Eclipse Resources Corporation Announces Public Offering of Common Stock
-
Gilead Sciences (GILD) Epclusa Approval Secures Near-Term HCV Dominance - BMO Capital
-
MEDIA ADVISORY: BMO Supports the LGBTQ+ Community With the 21st Annual Pride and Remembrance Run
-
BMO Capital Downgrades Magna Int'l (MGA) to Market Perform
-
Merck (MRK): Management Meeting Reinforced Bullish Views - BMO
-
BMO Capital Downgrades Regulus Therapeutics (RGLS) to Market Perform
-
Bank of Montreal Announces Conversion Privilege of $290,000,000 Non-Cumulative 5-Year Rate Reset Class B Preferred Shares, Series 25
-
Blue Ridge® Networks Expands Team of Senior Advisors
-
QEP Resources Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Biotech Top-Line Hit Should Be Minor, BMO Capital Says; Dollar Strength Creates FX Headwinds for Some
-
Atalaya Mining PLC: Appointment of Joint Corporate Broker
-
Bombardier to get $1 billion Quebec investment, eyes on federal talks
-
Janney Welcomes Accomplished Investment Banker to its Lodging & Leisure Team
-
BMO Welcomes the Argos to BMO Field
-
Jones Lang LaSalle (JLL) Enters Amended, Expanded Credit Facility
-
JLL Expands Credit Facility to Reinforce Strong Financial Profile
-
Osisko Corporate Update
-
QEP Resources (QEP) Prices 20M Share Common Stock Offering for Proceeds of ~$367M
-
QEP Resources Announces Pricing of Offering of Common Stock
-
QEP Resources (QEP) Announces 20M Offering of Common Stock
-
QEP Resources Announces Offering of Common Stock
-
Insight Venture Partners Expands Capital Markets Team
-
BMO Marks 20th National Aboriginal Day With In-Branch Celebrations
-
Fate Therapeutics (FATE) Fast Track Provides Greater FDA Access - BMO Capital
-
DoubleLine Income Solutions Trust Announces Monthly Cash Distribution

